Aurobindo Pharma Q3 Results: Revenue beats estimates, profit and margin under pressure

Ahead of earnings announcement, shares of Aurobindo Pharma ended the trading session flat at ₹1,184.50 apiece on the BSE, down 0.62%. 

Leave a Reply

Your email address will not be published. Required fields are marked *